Duck Creek Technologies Inc (DCT) Fundamental Analysis & Valuation

NASDAQ:DCTUS2641201064

Current stock price

18.99 USD
0 (0%)
At close:
18.99 USD
0 (0%)
After Hours:

This DCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DCT Profitability Analysis

1.1 Basic Checks

  • In the past year DCT was profitable.
  • DCT had a positive operating cash flow in the past year.
DCT Yearly Net Income VS EBIT VS OCF VS FCFDCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

1.2 Ratios

  • The profitability ratios for DCT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCT Yearly ROA, ROE, ROICDCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -1 -2 -3 -4

1.3 Margins

  • DCT has a Gross Margin of 56.63%. This is in the lower half of the industry: DCT underperforms 63.00% of its industry peers.
  • DCT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
DCT Yearly Profit, Operating, Gross MarginsDCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 40

8

2. DCT Health Analysis

2.1 Basic Checks

  • DCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DCT has been increased compared to 1 year ago.
  • DCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DCT Yearly Shares OutstandingDCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
DCT Yearly Total Debt VS Total AssetsDCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 15.48 indicates that DCT is not in any danger for bankruptcy at the moment.
  • DCT has a better Altman-Z score (15.48) than 95.33% of its industry peers.
  • There is no outstanding debt for DCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.48
ROIC/WACCN/A
WACC12.39%
DCT Yearly LT Debt VS Equity VS FCFDCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.68 indicates that DCT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 4.68, DCT belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
  • DCT has a Quick Ratio of 4.68. This indicates that DCT is financially healthy and has no problem in meeting its short term obligations.
  • DCT has a better Quick ratio (4.68) than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.68
DCT Yearly Current Assets VS Current LiabilitesDCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 100M 200M 300M 400M

5

3. DCT Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.00% over the past year.
  • The Revenue has grown by 12.81% in the past year. This is quite good.
  • Measured over the past years, DCT shows a quite strong growth in Revenue. The Revenue has been growing by 14.09% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%

3.2 Future

  • DCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.83% yearly.
  • The Revenue is expected to grow by 14.02% on average over the next years. This is quite good.
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCT Yearly Revenue VS EstimatesDCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DCT Yearly EPS VS EstimatesDCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.05 0.1 0.15 0.2 0.25

3

4. DCT Valuation Analysis

4.1 Price/Earnings Ratio

  • DCT is valuated quite expensively with a Price/Earnings ratio of 189.90.
  • DCT's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, DCT is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 96.14, the valuation of DCT can be described as expensive.
  • DCT's Price/Forward Earnings ratio is in line with the industry average.
  • DCT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
DCT Price Earnings VS Forward Price EarningsDCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCT indicates a somewhat cheap valuation: DCT is cheaper than 65.00% of the companies listed in the same industry.
  • 66.67% of the companies in the same industry are more expensive than DCT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 101.39
EV/EBITDA 244.38
DCT Per share dataDCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCT does not grow enough to justify the current Price/Earnings ratio.
  • DCT's earnings are expected to grow with 29.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)9
PEG (5Y)N/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%

3

5. DCT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.26%, DCT has a reasonable but not impressive dividend return.
  • DCT's Dividend Yield is rather good when compared to the industry average which is at 0.64. DCT pays more dividend than 86.00% of the companies in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.89, DCT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

  • DCT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DCT Yearly Dividends per shareDCT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%
DCT Yearly Income VS Free CF VS DividendDCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

DCT Fundamentals: All Metrics, Ratios and Statistics

Duck Creek Technologies Inc

NASDAQ:DCT (3/29/2023, 8:01:09 PM)

After market: 18.99 0 (0%)

18.99

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-29
Earnings (Next)06-27
Inst Owners0%
Inst Owner Change0%
Ins Owners1.33%
Ins Owner Change0%
Market Cap2.52B
Revenue(TTM)310.08M
Net Income(TTM)-14.19M
Analysts46.67
Price Target16.47 (-13.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)687.25%
Min EPS beat(2)67.06%
Max EPS beat(2)1307.44%
EPS beat(4)3
Avg EPS beat(4)570.06%
Min EPS beat(4)67.06%
Max EPS beat(4)1307.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.54%
Min Revenue beat(2)4.14%
Max Revenue beat(2)8.94%
Revenue beat(4)3
Avg Revenue beat(4)4.16%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)8.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)5.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.62%
EPS NY rev (1m)0%
EPS NY rev (3m)18.92%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
P/S 8.14
P/FCF 101.39
P/OCF 85.71
P/B 3.45
P/tB 8.57
EV/EBITDA 244.38
EPS(TTM)0.1
EY0.53%
EPS(NY)0.2
Fwd EY1.04%
FCF(TTM)0.19
FCFY0.99%
OCF(TTM)0.22
OCFY1.17%
SpS2.33
BVpS5.5
TBVpS2.22
PEG (NY)9
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.63%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.72%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.68
Altman-Z 15.48
F-Score5
WACC12.39%
ROIC/WACCN/A
Cap/Depr(3y)19.14%
Cap/Depr(5y)28.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A
EBIT growth 1Y-38.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.99%
EBIT Next 3Y42.3%
EBIT Next 5YN/A
FCF growth 1Y269.82%
FCF growth 3Y5.03%
FCF growth 5YN/A
OCF growth 1Y151.66%
OCF growth 3Y-10.23%
OCF growth 5YN/A

Duck Creek Technologies Inc / DCT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Duck Creek Technologies Inc (DCT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DCT.


Can you provide the valuation status for Duck Creek Technologies Inc?

ChartMill assigns a valuation rating of 1 / 10 to Duck Creek Technologies Inc (DCT). This can be considered as Overvalued.


What is the profitability of DCT stock?

Duck Creek Technologies Inc (DCT) has a profitability rating of 1 / 10.


Can you provide the financial health for DCT stock?

The financial health rating of Duck Creek Technologies Inc (DCT) is 9 / 10.


Can you provide the expected EPS growth for DCT stock?

The Earnings per Share (EPS) of Duck Creek Technologies Inc (DCT) is expected to grow by 21.11% in the next year.